Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

DEPOIMENTO DE JOSÉ ADILSON DANTAS

View through CrossRef
Transcrição autorizada do depoimento concedido pelo ex-aluno de Heloísa Liberalli Bellotto, José Adilson Dantas, para o vídeo “Homenagem à professora Heloísa Bellotto”, produzido pela Faculdade de Ciência da Informação (FCI) da Universidade de Brasília – UnB. Transcrição livre realizada por Ana Célia Navarro de Andrade. Disponível em: https://www.youtube.com/watch?v=0aBeDr-18KY&t=10s
Title: DEPOIMENTO DE JOSÉ ADILSON DANTAS
Description:
Transcrição autorizada do depoimento concedido pelo ex-aluno de Heloísa Liberalli Bellotto, José Adilson Dantas, para o vídeo “Homenagem à professora Heloísa Bellotto”, produzido pela Faculdade de Ciência da Informação (FCI) da Universidade de Brasília – UnB.
Transcrição livre realizada por Ana Célia Navarro de Andrade.
Disponível em: https://www.
youtube.
com/watch?v=0aBeDr-18KY&t=10s.

Related Results

Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Protecting stable biological nomenclatural systems enables universal communication: A collective international appeal
Abstract The fundamental value of universal nomenclatural systems in biology is that they enable unambiguous scientific communication. However, the stability of thes...
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
OBJECTIVE In observational data, lower levels of lipoprotein(a) have been associated with greater prevalence of type 2 diabetes. Whether pharmacologic lowering of...
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Abstract The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurre...
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk. Whether apoB levels and apoB lowering hold incremental predictive information on...
Pesquisa e cuidado à saúde no Instituto Fernandes Figueira: depoimento de José Augusto de Britto
Pesquisa e cuidado à saúde no Instituto Fernandes Figueira: depoimento de José Augusto de Britto
Resumo O depoimento resulta de entrevista realizada com José Augusto Alves de Britto, médico pediatra que ocupou o cargo de diretor do Instituto Fernandes Figueira entre 2001 e 200...
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA
BACKGROUND: In ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches), an invasive strategy demonstrated better...

Back to Top